Inogen (NASDAQ: INGN) — Perfil da empresa, notícias e dados financeiros
Inogen specializes in portable oxygen concentrators to improve mobility and quality of life for patients with respiratory conditions.
Inogen
Inogen (NASDAQ:INGN) specializes in innovative respiratory products, primarily focusing on portable oxygen concentrators for patients suffering from chronic respiratory conditions. Their aim is not just to improve patient mobility but to enhance the overall quality of life for those requiring oxygen therapy. The core of Inogen's operations is to design, manufacture, and market these portable devices, which stand out for their efficiency, reliability, and user-friendliness. Inogen is dedicated to ongoing research and development, striving to advance their technology and expand their product portfolio to meet the evolving needs of the healthcare sector. Their objective is to ensure that people worldwide can lead a more liberated life, free from the constraints that traditional oxygen therapy methods may impose.
Resumo
Operações
Produtos e/ou serviços de Inogen
- Portable oxygen concentrators designed to provide users with independence and mobility while receiving oxygen therapy.
- Home oxygen concentrators offering a stationary solution for oxygen therapy needs at home.
- G5 portable oxygen concentrator, their latest model known for its lightweight design and extended battery life.
- Comprehensive customer support services aimed at assisting patients with technical support, insurance questions, and product information.
- Connectivity solutions integrated into oxygen devices for tracking device health, usage and providing data to healthcare providers.
- Accessories and parts including batteries, carry bags, and external chargers to enhance and maintain the functionality of the oxygen concentrators.
equipe executiva do Inogen
- Kevin R. M. SmithPresident, CEO & Director
- Kevin P. SmithGeneral Counsel, Secretary & Executive VP of Business Development
- Jennifer Yi BoyerExecutive VP of Enterprise Enablement & Chief Human Resources Officer
- Jason A. RichardsonCFO, Executive VP & Treasurer
- Andrew P. RedingExecutive VP & COO
- Mary WrightVP & Chief Accounting Officer
- Naga RameswamyChief Technology Officer
- Lorna WilliamsSenior Vice President of Investor Relations
- Dominic HultonChief Marketing Officer
- Philip CorrinSenior Vice President of Operations & Supply Chain
Principais indicadores financeiros
Resultados divulgados pela Inogen, em USD.
- Cap. de mercado
- 192,4 mi
- Receita (TTM)
- 354,3 mi
- P/L
- —
- LPA (diluído, TTM)
- -0.9
- Dividend yield
- —
- Margem de lucro
- -6.9%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 348,7 mi | -30,2 mi | -22,7 mi | |
| 335,7 mi | -42,5 mi | -35,9 mi | |
| 315,7 mi | -109,4 mi | -102,4 mi | |
| 377,2 mi | -85,2 mi | -83,8 mi |